Are peptidomimetics the next important step in management of advanced prostate cancer?

A team of researchers at the University of Texas Southwestern Medical Center in San Antonio are suggesting that a products known as peptidomimetics may represent an important new opportunity because of the way in which they impact androgen signaling. … READ MORE …